1-155904739-C-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000368323.8(RIT1):āc.229G>Cā(p.Ala77Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000000686 in 1,457,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A77G) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000368323.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIT1 | NM_006912.6 | c.229G>C | p.Ala77Pro | missense_variant | 4/6 | ENST00000368323.8 | NP_008843.1 | |
RIT1 | NM_001256821.2 | c.280G>C | p.Ala94Pro | missense_variant | 4/6 | NP_001243750.1 | ||
RIT1 | NM_001256820.2 | c.121G>C | p.Ala41Pro | missense_variant | 3/5 | NP_001243749.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIT1 | ENST00000368323.8 | c.229G>C | p.Ala77Pro | missense_variant | 4/6 | 1 | NM_006912.6 | ENSP00000357306 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1457666Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 725490
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Noonan syndrome 8 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 08, 2021 | For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the p.Ala77 amino acid residue in RIT1 have been observed in affected individuals (PMID: 26714497, 2657980, 27101134). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. Experimental studies have shown that cells expressing this variant demonstrate enhanced p-ERK levels compared with wildtype (PMID: 25049390). This variant has been reported in an individual with Noonan syndrome (PMID: 25049390). ClinVar contains an entry for this variant (Variation ID: 228289). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with proline at codon 77 of the RIT1 protein (p.Ala77Pro). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and proline. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 05, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 21, 2023 | Published previously in association with Noonan syndrome (Chen et al., 2014; Cav et al., 2016); Published functional studies demonstrate a damaging effect through increased RAS-ERK pathway activation (Chen et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26757980, 27226556, 26446362, 24803665, 25959749, 27101134, 30904604, 25049390) - |
Noonan syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 03, 2016 | The p.Ala94Pro variant in RIT1 (reported as p.Ala77Pro on NM_006912.5) has been identified in 1 individual with Noonan syndrome (Chen 2014). It was absent from large population studies. In vitro functional studies suggest that this variant promotes ERK activation (Chen 2014); however, these assays may not accurately re present biological function. In addition, another variant at the same position ( p.Ala77Thr) has been reported in 2 individuals with Noonan syndrome, occurring d e novo in one family and segregating with the disease in 1 affected family membe r in the other family (Cave 2016). Computational prediction tools and conservati on analysis suggest that the p.Ala94Pro variant may impact the protein, though t his information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical signif icance, the p.Ala94Pro variant is likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at